1681 Pemilikan Institusi, Pembeli - Consun Pharmaceutical Group Limited

Pemilikan Institusi dan Dana - Pembeli

Pemegang utama yang telah membuka kedudukan baru dalam Consun Pharmaceutical Group Limited termasuk AVES - Avantis Emerging Markets Value ETF, REMG - Emerging Markets Equity Active ETF, AVSE - Avantis Responsible Emerging Markets Equity ETF, dan HSDEX - Hartford Schroders Diversified Emerging Markets Fund Class SDR .

Halaman ini menunjukkan perubahan dalam struktur pemilikan dengan menyenaraikan institusi, dana dan pemegang saham utama yang telah meningkatkan pegangan mereka atau membuka kedudukan baru dalam tempoh pelaporan yang lalu. Baris hijau menunjukkan kedudukan baru. Klik pautan ikon untuk melihat sejarah transaksi penuh.

Tingkatkan untuk membuka data premium.

Tarikh Fail	Sumber	Pelabur	Saham	ΔSaham (%)	Nilai Dilaporkan ($1000)	Δ Nilai (%)
2025-07-28	NP	AVSE - Avantis Responsible Emerging Markets Equity ETF	28,000		38
2025-07-25	NP	EEMS - iShares MSCI Emerging Markets Small-Cap ETF This fund is a listed as child fund of BlackRock Inc. and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	118,000		159
2025-07-28	NP	AVEM - Avantis Emerging Markets Equity ETF This fund is a listed as child fund of American Century Companies Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	948,000	46.07	1,280	91.90
2025-06-26	NP	FISMX - Fidelity International Small Cap Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	22,500,000	81.47	26,864	114.52
2025-08-27	NP	THRIVENT SERIES FUND INC - Thrivent International Allocation Portfolio Class A	191,000	24.03	276	51.10
2025-08-28	NP	SIEMX - SIT EMERGING MARKETS EQUITY FUND - CLASS F, effective 1-31-2017 (formerly Class A)	293,211	171.49	423	230.47
2025-07-29	NP	GBFFX - GMO Benchmark-Free Fund Class III	399,000	12.08	539	46.99
2025-06-26	NP	Dimensional Emerging Markets Value Fund - Dimensional Emerging Markets Value Fund This fund is a listed as child fund of Dimensional Fund Advisors Lp and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	2,111,000	0.81	2,514	18.70
2025-06-26	NP	Thrivent Core Funds - Thrivent Core Emerging Markets Equity Fund	761,000	14.26	906	34.62
2025-07-29	NP	GMEMX - GMO Emerging Markets Fund Class II	1,461,000	27.49	1,973	67.35
2025-08-18	NP	PACIFIC SELECT FUND - International Small-Cap Portfolio Class I	1,828,000	11.19	2,640	35.40
2025-07-29	NP	GIMFX - GMO Implementation Fund	760,000	16.21	1,026	52.45
2025-08-20	NP	REMG - Emerging Markets Equity Active ETF	35,000		50
2025-06-30	NP	VFSNX - Vanguard FTSE All-World ex-US Small-Cap Index Fund Institutional Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	1,455,000	3.26	1,733	21.54
2025-06-26	NP	HSDEX - Hartford Schroders Diversified Emerging Markets Fund Class SDR	24,000		29
2025-07-28	NP	AVES - Avantis Emerging Markets Value ETF This fund is a listed as child fund of American Century Companies Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	55,000		74
2025-07-28	NP	AVEE - Avantis Emerging Markets Small Cap Equity ETF	23,000	9.52	31	47.62
2025-06-26	NP	FLKSX - Fidelity Low-Priced Stock K6 Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	606,657	2.14	724	20.87
2025-08-28	NP	QCSTRX - Stock Account Class R1	1,518,000	2.85	2,192	25.20

HK:1681 / Consun Pharmaceutical Group Limited - Pemilikan Institusi - Pembeli

Pemilikan Institusi dan Dana - Pembeli

Other Listings

US:CPHGF
DE:C1P	€1.51